EZH2 and diffuse large B-cell lymphoma: Nonetheless, as previously stated, we found similar and rather high EZH2 expression levels in both GC and non-GC DLBCL, which raises the question of whether treatment indication might be extended to non-mutated cases (of both molecular groups) in the future.